👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

UnitedHealth reports Q3 earnings and revenue above estimates; shares down

Published 2024-10-15, 06:10 a/m
© Reuters.
UNH
-

Investing.com -- UnitedHealth reported third-quarter earnings and revenue that exceeded analyst expectations.

The health insurer posted Q3 earnings per share (EPS) of $7.15, topping the consensus estimate of $7.02. Revenue came in at $100.82 billion, also above the estimated $99.14 billion.

The company’s shares fell around 2% in premarket trading Tuesday.

The UnitedHealthcare segment generated $74.9 billion in revenue, reflecting a 7.2% year-over-year increase, and exceeding the estimated $73.65 billion.

Meanwhile, Optum's revenue grew 13% year-over-year to $63.9 billion.

“Our continued growth, which positions us well for the coming years, is rooted in the innovative products and responsive service of our people that are embraced each day across the full range of health care participants,” said Andrew Witty, CEO of UnitedHealth Group (NYSE:UNH).

UnitedHealth said its full-year adjusted net earnings outlook remains between $27.50 and $27.75, in line with the $27.50 to $28.00 range set nearly a year ago.

This guidance includes absorbing an estimated $0.75 per share in business disruption costs from Change Healthcare (NASDAQ:CHNG) services, an increase of approximately $0.10 per share from last quarter’s estimate.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.